Description

Fladrafinil Tablets

Fladrafinil
CAS Number	90212-80-9
Molar Mass	325.3 g/mol
Chemical Formula	C15H13F2NO3S
IUPAC Name	2-[bis(4-fluorophenyl)methylsulfinyl]-N-hydroxyacetamide

Introduction

Fladrafinil Tablets represent a dedicated research product tailored exclusively for scientific exploration, with no connotation of human consumption. Harnessing the distinctive properties of fladrafinil, these tablets serve as a valuable tool for researchers delving into the realms of cognitive function and neurotransmitter modulation.

Key Characteristics

Fladrafinil, a derivative of adrafinil, possesses unique characteristics that make it a focus of cognitive research. Its potential to influence neurotransmitters, notably dopamine, serotonin, norepinephrine, histamine, and orexin systems, positions it as an intriguing compound for neuroscientific investigations.

Research Applications

Fladrafinil Tablets find applications in diverse research domains, including the exploration of its anti-aggressive effects in animal studies. additionally, it has been investigated for its potential to stimulate the dopamine, serotonin, norepinephrine, histamine, and orexin systems in the brain.

Research Benefits

Anti-aggressive Effects in Animal Studies

Studies in animal models suggest that fladrafinil may exhibit anti-aggressive effects. Understanding its impact on aggressive behavior provides valuable insights into its potential neurobehavioral effects.

Potentially Stimulate Dopamine, Serotonin, Norepinephrine, Histamine, and Orexin Systems

Research indicates that fladrafinil has the potential to stimulate multiple neurotransmitter systems in the brain, including dopamine, serotonin, norepinephrine, histamine, and orexin. Exploring these effects contributes to a comprehensive understanding of its neurochemical interactions.

Summary

Fladrafinil Tablets, designed for rigorous scientific exploration, offer researchers an opportunity to delve into the anti-aggressive effects observed in animal studies and the potential stimulation of various neurotransmitter systems. This research benefits position fladrafinil as a promising subject for further investigation into neurobehavioral and cognitive effects.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.

Upon the finalization of your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. Should you find any dissatisfaction with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected].

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References

1. Luca G, Bandarabadi M, Konofal E, Lecendreux M, Ferrié L, Figadère B, Tafti M. Lauflumide (NLS-4) Is a New Potent Wake-Promoting Compound. Front Neurosci. 2018 Aug 15;12:519. doi: 10.3389/fnins.2018.00519. PMID: 30158846; PMCID: PMC6104159. [Read More]